Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cybin Inc. Common Shares
(NY:
CYBN
)
9.150
+0.090 (+0.99%)
Official Closing Price
Updated: 4:10 PM EST, Dec 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc. Common Shares
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
38
39
Next >
Cybin to Participate in Upcoming Scientific and Investor Conferences
September 21, 2022
From
Cybin Inc.
Via
Business Wire
Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today
September 20, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.83% at $0.62
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces R&B Milestones, Beats Anticipated Timeframe
September 20, 2022
Via
Investor Brand Network
Study Finds That LSD Temporarily Reduces Binge Drinking in Rodents
September 07, 2022
Via
Investor Brand Network
Hamilton Morris Confirmed as Keynote Speaker at Convergence Psychedelic Conference
September 20, 2022
Via
Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Clinical Trial Marks ‘Tremendous’ Milestone as First Participants Receive Initial CYB003 Dose
September 20, 2022
Via
Investor Brand Network
Cybin Achieves Research and Development Milestones Ahead of Projected Timelines
September 20, 2022
From
Cybin Inc.
Via
Business Wire
Psychedelic Stock Gainers And Losers From September 19, 2022
September 19, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.28% at $0.65
Via
Benzinga
The 5 Cannabis Categories Declined Between 3% And 11.5% Last Week
September 19, 2022
The cannabis sector consists of 5 distinctly different categories and they each perform quite differently.
Via
Talk Markets
8 Largest Psychedelic Stocks Continued Their Decline Last Week
September 18, 2022
The 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index were collectively down 10% in the past week. We also take a look at some therapy-clinic stocks.
Via
Talk Markets
Numinus Wellness, GH Research Among Top Psychedelic Movers Of Today
September 15, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 3.98% at $14.64
Via
Benzinga
Study Suggests Reported Psychedelics Microdosing Effects Are Due to User Expectancy
September 15, 2022
Via
Investor Brand Network
GH Research, Cybin Among Top Psychedelic Movers Of Today
September 14, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.26% at $13.81
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Marking Industry’s First-Ever Entry of Novel Psilocybin Analog into Clinical Development
September 14, 2022
Via
Investor Brand Network
Study Finds Hepatitis C Drugs May Help Alleviate Symptoms of PTSD
September 13, 2022
Via
Investor Brand Network
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
September 12, 2022
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 44.93% at $1.00
Via
Benzinga
How Psychedelic Legalization, Decriminalization and Medicalization Differ
September 12, 2022
Via
Investor Brand Network
Topics
Law Enforcement
Exposures
Legal
8 Largest Psychedelic Stocks Dropped Almost 12% This Week
September 10, 2022
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index, while they gained 18.5% in August, declined 11.6% this week. Also, a look into some clinic stocks.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From September 9, 2022
September 09, 2022
GAINERS: Allied (OTC:ALID) shares closed up 21.78% at $0.52
Via
Benzinga
Small Pharma, Seelos Therapeutics Among Top Psychedelic Movers Of Today
September 08, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 13.39% at $1.27
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) on Leading Edge of Psilocybin Research
September 08, 2022
Via
Investor Brand Network
Exposures
Censorship
Psychedelic Stock Gainers And Losers From September 7, 2022
September 07, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.66% at $1.12
Via
Benzinga
Psychedelics May Make People Less Afraid of Death
September 07, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change...
Via
FinancialNewsMedia
Topics
Supply Chain
Exposures
Supply Chain
Psychedelic Stock Gainers And Losers From September 6, 2022
September 06, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.90% at $0.30 LOSERS:
Via
Benzinga
Largest Psychedelic Stocks Up In August; Up 42% Since End Of June
September 04, 2022
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index are on average UP 18.5% in August.
Via
Talk Markets
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
September 02, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.41% at $0.29
Via
Benzinga
Study Highlights Need for Postnatal Depression Screening
September 02, 2022
Via
Investor Brand Network
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
September 01, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.57% at $0.27 LOSERS:
Via
Benzinga
Study Shows Psilocybin Helps Alcoholics Reduce Drinking
September 01, 2022
Via
Investor Brand Network
Exposures
Product Safety
Psychedelic Stock Gainers And Losers From August 31, 2022
August 31, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 31.95% at $0.24
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
38
39
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.